Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters











Publication year range
2.
Nat Commun ; 15(1): 3480, 2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38658537

ABSTRACT

The analysis of neural circuits has been revolutionized by optogenetic methods. Light-gated chloride-conducting anion channelrhodopsins (ACRs)-recently emerged as powerful neuron inhibitors. For cells or sub-neuronal compartments with high intracellular chloride concentrations, however, a chloride conductance can have instead an activating effect. The recently discovered light-gated, potassium-conducting, kalium channelrhodopsins (KCRs) might serve as an alternative in these situations, with potentially broad application. As yet, KCRs have not been shown to confer potent inhibitory effects in small genetically tractable animals. Here, we evaluated the utility of KCRs to suppress behavior and inhibit neural activity in Drosophila, Caenorhabditis elegans, and zebrafish. In direct comparisons with ACR1, a KCR1 variant with enhanced plasma-membrane trafficking displayed comparable potency, but with improved properties that include reduced toxicity and superior efficacy in putative high-chloride cells. This comparative analysis of behavioral inhibition between chloride- and potassium-selective silencing tools establishes KCRs as next-generation optogenetic inhibitors for in vivo circuit analysis in behaving animals.


Subject(s)
Caenorhabditis elegans , Neurons , Optogenetics , Zebrafish , Animals , Caenorhabditis elegans/genetics , Neurons/metabolism , Neurons/physiology , Optogenetics/methods , Channelrhodopsins/metabolism , Channelrhodopsins/genetics , Humans , Drosophila , Potassium Channels/metabolism , Potassium Channels/genetics , Chlorides/metabolism , Animals, Genetically Modified , Behavior, Animal , HEK293 Cells , Drosophila melanogaster
3.
J Biol Chem ; 298(10): 102413, 2022 10.
Article in English | MEDLINE | ID: mdl-36007611

ABSTRACT

Cyclotides and acyclic versions of cyclotides (acyclotides) are peptides involved in plant defense. These peptides contain a cystine knot motif formed by three interlocked disulfide bonds, with the main difference between the two classes being the presence or absence of a cyclic backbone, respectively. The insecticidal activity of cyclotides is well documented, but no study to date explores the insecticidal activity of acyclotides. Here, we present the first in vivo evaluation of the insecticidal activity of acyclotides from Rinorea bengalensis on the vinegar fly Drosophila melanogaster. Of a group of structurally comparable acyclotides, ribe 31 showed the most potent toxicity when fed to D. melanogaster. We screened a range of acyclotides and cyclotides and found their toxicity toward human red blood cells was substantially lower than toward insect cells, highlighting their selectivity and potential for use as bioinsecticides. Our confocal microscopy experiments indicated their cytotoxicity is likely mediated via membrane disruption. Furthermore, our surface plasmon resonance studies suggested ribe 31 preferentially binds to membranes containing phospholipids with phosphatidyl-ethanolamine headgroups. Despite having an acyclic backbone, we determined the three-dimensional NMR solution structure of ribe 31 is similar to that of cyclotides. In summary, our results suggest that, with further optimization, ribe 31 could have applications as an insecticide due to its potent in vivo activity against D. melanogaster. More broadly, this work advances the field by demonstrating that acyclotides are more common than previously thought, have potent insecticidal activity, and have the advantage of potentially being more easily manufactured than cyclotides.


Subject(s)
Cyclotides , Drosophila melanogaster , Insecticides , Plant Proteins , Violaceae , Animals , Humans , Amino Acid Sequence , Cyclotides/chemistry , Cyclotides/isolation & purification , Cyclotides/pharmacology , Drosophila melanogaster/drug effects , Insecticides/chemistry , Insecticides/isolation & purification , Insecticides/pharmacology , Plant Proteins/chemistry , Plant Proteins/isolation & purification , Plant Proteins/pharmacology , Violaceae/chemistry , Erythrocytes/drug effects
5.
Nat Commun ; 12(1): 1458, 2021 03 05.
Article in English | MEDLINE | ID: mdl-33674589

ABSTRACT

Epitranscriptomic modifications can impact behavior. Here, we used Drosophila melanogaster to study N6-methyladenosine (m6A), the most abundant modification of mRNA. Proteomic and functional analyses confirm its nuclear (Ythdc1) and cytoplasmic (Ythdf) YTH domain proteins as major m6A binders. Assays of short term memory in m6A mutants reveal neural-autonomous requirements of m6A writers working via Ythdf, but not Ythdc1. Furthermore, m6A/Ythdf operate specifically via the mushroom body, the center for associative learning. We map m6A from wild-type and Mettl3 mutant heads, allowing robust discrimination of Mettl3-dependent m6A sites that are highly enriched in 5' UTRs. Genomic analyses indicate that Drosophila m6A is preferentially deposited on genes with low translational efficiency and that m6A does not affect RNA stability. Nevertheless, functional tests indicate a role for m6A/Ythdf in translational activation. Altogether, our molecular genetic analyses and tissue-specific m6A maps reveal selective behavioral and regulatory defects for the Drosophila Mettl3/Ythdf pathway.


Subject(s)
Adenosine/analogs & derivatives , Adenosine/metabolism , Drosophila melanogaster/physiology , Learning/physiology , Memory/physiology , 5' Untranslated Regions , Adenosine/genetics , Animals , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster/genetics , Female , Nuclear Proteins/metabolism , Proteomics , RNA Stability , RNA, Messenger/metabolism
6.
Neurosci Biobehav Rev ; 95: 361-382, 2018 12.
Article in English | MEDLINE | ID: mdl-30077573

ABSTRACT

Geneticists use olfactory conditioning in Drosophila to identify learning genes; however, little is known about how these genes are integrated into short-term memory (STM) pathways. Here, we investigated the hypothesis that the STM evidence base is weak. We performed systematic review and meta-analysis of the field. Using metrics to quantify variation between discovery articles and follow-up studies, we found that seven genes were both highly replicated, and highly reproducible. However, ∼80% of STM genes have never been replicated. While only a few studies investigated interactions, the reviewed genes could account for >1000% memory. This large summed effect size could indicate irreproducibility, many shared pathways, or that current assay protocols lack the specificity needed to identify core plasticity genes. Mechanistic theories of memory will require the convergence of evidence from system, circuit, cellular, molecular, and genetic experiments; systematic data synthesis is an essential tool for integrated neuroscience.


Subject(s)
Drosophila/genetics , Memory, Short-Term , Animals , Drosophila/physiology , Memory, Short-Term/physiology
7.
Nat Methods ; 14(3): 271-274, 2017 03.
Article in English | MEDLINE | ID: mdl-28114289

ABSTRACT

Optogenetics uses light exposure to manipulate physiology in genetically modified organisms. Abundant tools for optogenetic excitation are available, but the limitations of current optogenetic inhibitors present an obstacle to demonstrating the necessity of neuronal circuits. Here we show that anion channelrhodopsins can be used to specifically and rapidly inhibit neural systems involved in Drosophila locomotion, wing expansion, memory retrieval and gustation, thus demonstrating their broad utility in the circuit analysis of behavior.


Subject(s)
Behavior, Animal/drug effects , Drosophila/physiology , Neural Pathways/physiology , Optogenetics/methods , Rhodopsin/pharmacology , Action Potentials/physiology , Animals , Behavior, Animal/physiology , Light , Locomotion/physiology , Neurons/physiology , Organisms, Genetically Modified , Taste Perception/physiology , Voltage-Dependent Anion Channels/physiology
8.
Neurobiol Aging ; 41: 39-52, 2016 May.
Article in English | MEDLINE | ID: mdl-27103517

ABSTRACT

Amyloid beta (Aß) peptide aggregation is linked to the initiation of Alzheimer's disease; accordingly, aggregation-prone isoforms of Aß, expressed in the brain, shorten the lifespan of Drosophila melanogaster. However, the lethal effects of Aß are not apparent until after day 15. We used shibire(TS) flies that exhibit a temperature-sensitive paralysis phenotype as a reporter of proteostatic robustness. In this model, we found that increasing age but not Aß expression lowered the flies' permissive temperature, suggesting that Aß did not exert its lethal effects by proteostatic disruption. Instead, we observed that chemical challenges, in particular oxidative stressors, discriminated clearly between young (robust) and old (sensitive) flies. Using nuclear magnetic resonance spectroscopy in combination with multivariate analysis, we compared water-soluble metabolite profiles at various ages in flies expressing Aß in their brains. We observed 2 genotype-linked metabolomic signals, the first reported the presence of any Aß isoform and the second the effects of the lethal Arctic Aß. Lethality was specifically associated with signs of oxidative respiration dysfunction and oxidative stress.


Subject(s)
Amyloid beta-Peptides/metabolism , Amyloid beta-Peptides/toxicity , Brain/metabolism , Disease Models, Animal , Drosophila melanogaster , Proteostasis Deficiencies/etiology , Proteostasis Deficiencies/metabolism , Aging/metabolism , Alzheimer Disease/etiology , Animals , Oxidative Stress , Protein Isoforms/metabolism , Protein Isoforms/toxicity , Temperature
9.
Methods Mol Biol ; 1303: 227-39, 2016.
Article in English | MEDLINE | ID: mdl-26235070

ABSTRACT

Fruit flies (Drosophila melanogaster) have been widely used to study the cellular and molecular basis of human neurodegenerative disease. The biological similarities between the human and the fly have been explored successfully to further investigate the pathological basis of Alzheimer's disease (AD). Here, we discuss transgenic Drosophila models systems and the methodologies that have been employed in the study of AD.


Subject(s)
Alzheimer Disease , Drosophila melanogaster , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/metabolism , Animals , Brain/metabolism , Brain/pathology , Disease Models, Animal , Drosophila melanogaster/genetics , Drosophila melanogaster/metabolism , Drosophila melanogaster/physiology , Female , Hybridization, Genetic , Immunoblotting , Immunohistochemistry , Longevity , Male , Motor Activity , Solubility
10.
Dis Model Mech ; 8(7): 657-67, 2015 Jul 01.
Article in English | MEDLINE | ID: mdl-26035384

ABSTRACT

Metals, including iron, are present at high concentrations in amyloid plaques in individuals with Alzheimer's disease, where they are also thought to be cofactors in generating oxidative stress and modulating amyloid formation. In this study, we present data from several Drosophila models of neurodegenerative proteinopathies indicating that the interaction between iron and amyloid beta peptide (Aß) is specific and is not seen for other aggregation-prone polypeptides. The interaction with iron is likely to be important in the dimerisation of Aß and is mediated by three N-terminal histidines. Transgenic fly lines systematically expressing all combinations of His>Ala substitutions in Aß were generated and used to study the pathological role of these residues. Developmental eye phenotypes, longevity and histological examinations indicate that the N-terminal histidines have distinct position-dependent and -independent mechanisms. The former mediate the toxic effects of metals and Aß aggregation under non-oxidising conditions and the latter are relevant under oxidising conditions. Understanding how Aß mediates neurotoxic effects in vivo will help to better target pathological pathways using aggregation blockers and metal-modifying agents.


Subject(s)
Amyloid beta-Peptides/metabolism , Drosophila/metabolism , Iron/metabolism , Alzheimer Disease/etiology , Alzheimer Disease/genetics , Alzheimer Disease/metabolism , Amino Acid Substitution , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/genetics , Animals , Animals, Genetically Modified , Disease Models, Animal , Drosophila/genetics , Female , Ferritins/metabolism , Histidine/chemistry , Humans , In Vitro Techniques , Oxidation-Reduction , Phenotype , Protein Aggregates , Protein Aggregation, Pathological/etiology , Protein Aggregation, Pathological/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism
11.
Biochemistry ; 53(13): 2101-11, 2014 Apr 08.
Article in English | MEDLINE | ID: mdl-24601543

ABSTRACT

The aggregation of ß-amyloid (Aß) into toxic oligomers is a hallmark of Alzheimer's disease pathology. Here we present a novel approach for the development of peptides capable of preventing amyloid aggregation based upon the previous selection of natural all-l peptides that bind Aß1-42. Using an intracellular selection system, successful library members were further screened via competition selection to identify the most effective peptides capable of reducing amyloid levels. To circumvent potential issues arising from stability and protease action for these structures, we have replaced all l residues with d residues and inverted the sequence. These retro-inverso (RI) peptide analogues therefore encompass reversed sequences that maintain the overall topological order of the native peptides. Our results demonstrate that efficacy in blocking and reversing amyloid formation is maintained while introducing desirable properties to the peptides. Thioflavin-T assays, circular dichroism, and oblique angle fluorescence microscopy collectively indicate that RI peptides can reduce amyloid load, while 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays demonstrate modest reductions in cell toxicity. These conclusions are reinforced using Drosophila melanogaster studies to monitor pupal hatching rates and fly locomotor activity in the presence of RI peptides delivered via RI-trans-activating transcriptional activator peptide fusions. We demonstrate that the RI-protein fragment complementation assay approach can be used as a generalized method for deriving Aß-interacting peptides. This approach has subsequently led to several peptide candidates being further explored as potential treatments for Alzheimer's disease.


Subject(s)
Alzheimer Disease/drug therapy , Amyloid beta-Peptides/antagonists & inhibitors , Amyloid beta-Peptides/metabolism , Peptides/pharmacology , Peptides/therapeutic use , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Alzheimer Disease/prevention & control , Amyloid beta-Peptides/chemistry , Amyloid beta-Peptides/toxicity , Animals , Circular Dichroism , Disease Models, Animal , Drosophila melanogaster/drug effects , Drosophila melanogaster/metabolism , Motor Activity/drug effects , PC12 Cells , Peptide Fragments/antagonists & inhibitors , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Peptide Fragments/toxicity , Peptide Library , Peptides/chemistry , Peptides/isolation & purification , Plaque, Amyloid/drug therapy , Protein Structure, Secondary , Rats
12.
Biochim Biophys Acta ; 1832(12): 2115-26, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23911349

ABSTRACT

The accumulation of ß-amyloid (Aß) peptide in the brain is one of the pathological hallmarks of Alzheimer's disease and is thought to be of primary aetiological significance. In an unbiased genetic screen, we identified puromycin-sensitive aminopeptidase (PSA) as a potent suppressor of Aß toxicity in a Drosophila model system. We established that coexpression of Drosophila PSA (dPSA) in the flies' brains improved their lifespan, protected against locomotor deficits, and reduced brain Aß levels by clearing the Aß plaque-like deposits. However, confocal microscopy and subcellular fractionation of amyloid-expressing 7PA2 cells demonstrated that PSA localizes to the cytoplasm. Therefore, PSA and Aß are unlikely to be in the same cellular compartment; moreover, when we artificially placed them in the same compartment in flies, we could not detect a direct epistatic interaction. The consequent hypothesis that PSA's suppression of Aß toxicity is indirect was supported by the finding that Aß is not a proteolytic substrate for PSA in vitro. Furthermore, we showed that the enzymatic activity of PSA is not required for rescuing Aß toxicity in neuronal SH-SY5Y cells. We investigated whether the stimulation of autophagy by PSA was responsible for these protective effects. However PSA's promotion of autophagosome fusion with lysosomes required proteolytic activity and so its effect on autophagy is not identical to its protection against Aß toxicity.


Subject(s)
Alzheimer Disease/prevention & control , Aminopeptidases/pharmacology , Amyloid beta-Peptides/adverse effects , Brain/metabolism , Drosophila melanogaster/metabolism , Neuroblastoma/prevention & control , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Animals , Animals, Genetically Modified , Autophagy , Blotting, Western , Drosophila melanogaster/genetics , Drosophila melanogaster/growth & development , Enzyme-Linked Immunosorbent Assay , Flow Cytometry , Fluorescent Antibody Technique , Humans , Immunoenzyme Techniques , Neuroblastoma/metabolism , Neuroblastoma/pathology , Neurons/drug effects , Neurons/metabolism , Neurons/pathology , Proteolysis , Puromycin/pharmacology , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL